Spontaneous Formation of Extensive Vessel-Like Structures in Murine Engineered Heart Tissue

Tissue Engineering - Part A

Volumn 22, Issue 3-4, 2016, Pages 326-335

  Stoehr, Andrea ^a,b   Hirt, Marc N ^a,b   Hansen, Arne ^a,b   Seiffert, Moritz ^a,b,c   Conradi, Lenard ^a,b,c   Uebeler, June ^a,b   Limbourg, Florian P ^d   Eschenhagen, Thomas ^a,b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

^c UNIVERSITY HEART CENTER HAMBURG   (Germany)

^d HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL CELLS; MAMMALS; TISSUE;

BIOLOGICAL EFFECTS; CONVENTIONAL METHODS; ENGINEERED HEART TISSUES; SPONTANEOUS FORMATION; TUBULAR STRUCTURES; VASCULARIZATION; VESSEL STRUCTURE; VESSEL-LIKE STRUCTURES;

TISSUE ENGINEERING;

BETA GALACTOSIDASE; CRE RECOMBINASE; FIBRIN; HYDROXYTAMOXIFEN; TAMOXIFEN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOLOGICAL ACTIVITY; CONTROLLED STUDY; CULTURE MEDIUM; EMBRYO; ENDOTHELIUM; GENE EXPRESSION; HEART MUSCLE; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IN VITRO STUDY; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; SERUM; STAINING; TISSUE CULTURE; TISSUE ENGINEERING; TRANSGENIC MOUSE; VASCULARIZATION; ANGIOGENESIS; ANIMAL; CARDIAC MUSCLE; CARDIAC MUSCLE CELL; CORONARY BLOOD VESSEL; CYTOLOGY; GROWTH, DEVELOPMENT AND AGING; METABOLISM; PROCEDURES; SCID MOUSE;

ANIMALS; CORONARY VESSELS; MICE; MICE, SCID; MICE, TRANSGENIC; MYOCARDIUM; MYOCYTES, CARDIAC; NEOVASCULARIZATION, PHYSIOLOGIC; TISSUE ENGINEERING;

EID: 84959044298     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2015.0242     Document Type: Article

References (36)

1. Eschenhagen, T., Didie, M., Munzel, F., Schubert, P., Schneiderbanger, K., and Zimmermann, W. H. 3D engineered heart tissue for replacement therapy. Basic Res Cardiol 97 Suppl 1, I146, 2002.
2. Zimmermann, W. H., Didie, M., Wasmeier, G. H., Nixdorff, U., Hess, A., Melnychenko, I., Boy, O., Neuhuber, W. L., Weyand, M., and Eschenhagen, T. Cardiac grafting of engineered heart tissue in syngenic rats. Circulation 106, I151, 2002.
3. Zimmermann, W. H., and Eschenhagen, T. Cardiac tissue engineering for replacement therapy. Heart Fail Rev 8, 259, 2003.
4. Zimmermann, W. H., Melnychenko, I., Wasmeier, G., Didie, M., Naito, H., Nixdorff, U., Hess, A., Budinsky, L., Brune, K., Michaelis, B., Dhein, S., Schwoerer, A., Ehmke, H., and Eschenhagen, T. Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nat Med 12, 452, 2006.
5. Shimizu, T., Yamato, M., Isoi, Y., Akutsu, T., Setomaru, T., Abe, K., Kikuchi, A., Umezu, M., and Okano, T. Fabrication of pulsatile cardiac tissue grafts using a novel 3-dimensional cell sheet manipulation technique and temperature-responsive cell culture surfaces. Circ Res 90, e40, 2002.
6. Sekine, H., Shimizu, T., Hobo, K., Sekiya, S., Yang, J., Yamato, M., Kurosawa, H., Kobayashi, E., and Okano, T. Endothelial cell coculture within tissue-engineered cardiomyocyte sheets enhances neovascularization and improves cardiac function of ischemic hearts. Circulation 118, S145, 2008.
7. Benedito, R., Rocha, S. F., Woeste, M., Zamykal, M., Radtke, F., Casanovas, O., Duarte, A., Pytowski, B., and Adams, R. H. Notch-dependent VEGFR3 upregulation allows angiogenesis without VEGF-VEGFR2 signalling. Nature 484, 110, 2012.
8. Hansen, A., Eder, A., Bonstrup, M., Flato, M., Mewe, M., Schaaf, S., Aksehirlioglu, B., Schworer, A., Uebeler, J., and Eschenhagen, T. Development of a drug screening platform based on engineered heart tissue. Circ Res 107, 35, 2010.
9. Stohr, A., Friedrich, F. W., Flenner, F., Geertz, B., Eder, A., Schaaf, S., Hirt, M. N., Uebeler, J., Schlossarek, S., Carrier, L., Hansen, A., and Eschenhagen, T. Contractile abnormalities and altered drug response in engineered heart tissue from Mybpc3-targeted knock-in mice. J Mol Cell Cardiol 63, 189, 2013.
10. Jaisser, F. Inducible gene expression and gene modification in transgenic mice. J Am Soc Nephrol 11 Suppl 16, S95, 2000.
11. Turlo, K. A., Gallaher, S. D., Vora, R., Laski, F. A., and Iruela-Arispe, M. L. When Cre-mediated recombination in mice does not result in protein loss. Genetics 186, 959, 2010.
12. Reinert, R. B., Kantz, J., Misfeldt, A. A., Poffenberger, G., Gannon, M., Brissova, M., and Powers, A. C. Tamoxifeninduced Cre-loxP recombination is prolonged in pancreatic islets of adult mice. PLoS One 7, e33529, 2012.
13. Buelow, B., and Scharenberg, A. M. Characterization of parameters required for effective use of tamoxifen-regulated recombination. PLoS One 3, e3264, 2008.
14. Chong, J. J., Yang, X., Don, C. W., Minami, E., Liu, Y. W., Weyers, J. J., Mahoney, W. M., Van Biber, B., Cook, S. M., Palpant, N. J., Gantz, J. A., Fugate, J. A., Muskheli, V., Gough, G. M., Vogel, K. W., Astley, C. A., Hotchkiss, C. E., Baldessari, A., Pabon, L., Reinecke, H., Gill, E. A., Nelson, V., Kiem, H. P., Laflamme, M. A., and Murry, C. E. Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts. Nature 510, 273, 2014.
15. Ausoni, S., Zaglia, T., Dedja, A., Di Lisi, R., Seveso, M., Ancona, E., Thiene, G., Cozzi, E., and Schiaffino, S. Hostderived circulating cells do not significantly contribute to cardiac regeneration in heterotopic rat heart transplants. Cardiovasc Res 68, 394, 2005.
16. Krenning, G., Zeisberg, E. M., and Kalluri, R. The origin of fibroblasts and mechanism of cardiac fibrosis. J Cell Physiol 225, 631, 2010.
17. Brown, K. J., Maynes, S. F., Bezos, A., Maguire, D. J., Ford, M. D., and Parish, C. R. A novel in vitro assay for human angiogenesis. Lab Invest 75, 539, 1996.
18. Hogg, N., Browning, J., Howard, T., Winterford, C., Fitzpatrick, D., and Gobe, G. Apoptosis in vascular endothelial cells caused by serum deprivation, oxidative stress and transforming growth factor-beta. Endothelium 7, 35, 1999.
19. Lawlor, M. A., and Rotwein, P. Insulin-like growth factormediated muscle cell survival: central roles for Akt and cyclin-dependent kinase inhibitor p21. Mol Cell Biol 20, 8983, 2000.
20. Zimmermann, W. H., Schneiderbanger, K., Schubert, P., Didie, M., Munzel, F., Heubach, J. F., Kostin, S., Neuhuber, W. L., and Eschenhagen, T. Tissue engineering of a differentiated cardiac muscle construct. Circ Res 90, 223, 2002.
21. Naito, H., Melnychenko, I., Didie, M., Schneiderbanger, K., Schubert, P., Rosenkranz, S., Eschenhagen, T., and Zimmermann, W. H. Optimizing engineered heart tissue for therapeutic applications as surrogate heart muscle. Circulation 114, I72, 2006.
22. Honsho, S., Nishikawa, S., Amano, K., Zen, K., Adachi, Y., Kishita, E., Matsui, A., Katsume, A., Yamaguchi, S., Nishikawa, K., Isoda, K., Riches, D. W., Matoba, S., Okigaki, M., and Matsubara, H. Pressure-mediated hypertrophy and mechanical stretch induces IL-1 release and subsequent IGF-1 generation to maintain compensative hypertrophy by affecting Akt and JNK pathways. Circ Res 105, 1149, 2009.
23. Latronico, M. V., Costinean, S., Lavitrano, M. L., Peschle, C., and Condorelli, G. Regulation of cell size and contractile function by AKT in cardiomyocytes. Ann N Y Acad Sci 1015, 250, 2004.
24. Mohamed, S. N., Holmes, R., and Hartzell, C. R. Aserum-free, chemically-defined medium for function and growth of primary neonatal rat heart cell cultures. In Vitro 19, 471, 1983.
25. Palmer, J. N., Hartogensis, W. E., Patten, M., Fortuin, F. D., and Long, C. S. Interleukin-1 beta induces cardiac myocyte growth but inhibits cardiac fibroblast proliferation in culture. J Clin Invest 95, 2555, 1995.
26. Tomasek, J. J., Gabbiani, G., Hinz, B., Chaponnier, C., and Brown, R. A. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol 3, 349, 2002.
27. Pandya, N. M., Dhalla, N. S., and Santani, D. D. Angiogenesis - A new target for future therapy. Vascul Pharmacol 44, 265, 2006.
28. Sukmana, I. Microvascular guidance: a challenge to support the development of vascularised tissue engineering construct. ScientificWorldJournal 2012, 201352, 2012.
29. Kaully, T., Kaufman-Francis, K., Lesman, A., and Levenberg, S. Vascularization-the conduit to viable engineered tissues. Tissue Eng Part B Rev 15, 159, 2009.
30. Leor, J., Landa, N., and Cohen, S. Renovation of the injured heart with myocardial tissue engineering. Expert Rev Cardiovasc Ther 4, 239, 2006.
31. Levenberg, S., Rouwkema, J., Macdonald, M., Garfein, E. S., Kohane, D. S., Darland, D. C., Marini, R., van Blitterswijk, C. A., Mulligan, R. C., D'Amore, P. A., and Langer, R. Engineering vascularized skeletal muscle tissue. Nat Biotechnol 23, 879, 2005.
32. Hirt, M. N., Hansen, A., and Eschenhagen, T. Cardiac tissue engineering: state of the art. Circ Res 114, 354, 2014.
33. Vollert, I., Seiffert, M., Bachmair, J., Sander, M., Eder, A., Conradi, L., Vogelsang, A., Schulze, T., Uebeler, J., Holnthoner, W., Redl, H., Reichenspurner, H., Hansen, A., and Eschenhagen, T. In-vitro perfusion of engineered heart tissue through endothelialized channels. Tissue Eng Part A 20, 854, 2014.
34. Haraguchi, Y., Shimizu, T., Sasagawa, T., Sekine, H., Sakaguchi, K., Kikuchi, T., Sekine, W., Sekiya, S., Yamato, M., Umezu, M., and Okano, T. Fabrication of functional three-dimensional tissues by stacking cell sheets in vitro. Nat Protoc 7, 850, 2012.
35. Tee, R., Lokmic, Z., Morrison, W. A., and Dilley, R. J. Strategies in cardiac tissue engineering. ANZ J Surg 80, 683, 2010.
36. Fiedler, J., Stohr, A., Gupta, S. K., Hartmann, D., Holzmann, A., Just, A., Hansen, A., Hilfiker-Kleiner, D., Eschenhagen, T., and Thum, T. Functional MicroRNA library screening identifies the HypoxaMiR MiR-24 as a potent regulator of smooth muscle cell proliferation and vascularization. Antioxid Redox Signal 21, 1167, 2014.